Therapy: The risk of herpes zoster: Another cost of anti-TNF therapy?

Tim Bongartz, Robert Orenstein

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Several studies have shown that tumor necrosis factor (tNF) inhibitors are associated with an overall increased risk of serious infections compared with standard immunosuppressive regimens in patients with rheumatoid arthritis (ra). a study by Strangfeld et al. adds specificity by showing a moderately increased risk of herpes zoster in patients receiving anti-tNF antibody treatment, and raises the question of whether live zoster vaccines should be utilized in this patient group.

Original languageEnglish (US)
Pages (from-to)361-363
Number of pages3
JournalNature Reviews Rheumatology
Issue number7
StatePublished - Jul 2009

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Therapy: The risk of herpes zoster: Another cost of anti-TNF therapy?'. Together they form a unique fingerprint.

Cite this